Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Mitral Valve Surgery
- Conditions
- Mitral Valve Disease
- Interventions
- Procedure: Surgical cut-down and arterial puncture under direct visionProcedure: Percutaneous arteriotomy closed using a plug-based arteriotomy closure device
- Registration Number
- NCT03697941
- Lead Sponsor
- Karolinska University Hospital
- Brief Summary
A single-center prospective study. Patients undergoing minimally invasive mitral valve surgery between February 2016 and December 2018 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed either with surgical cut-down and arterial puncture under direct vision or percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA, Essential Medical Inc., Malvern, Pennsylvania). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review and from the Swedish Web system for Enhancement and Development of Evidence based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) electronic data collection platform.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 268
- Operated with minimally invasive mitral valve surgery between February 2016 and March 2019 at the Karolinska University Hospital in Stockholm, Sweden, with use of either surgical cut-down and arterial puncture under direct vision or percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device.
- None.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Surgical cut-down and arterial puncture under direct vision Surgical cut-down and arterial puncture under direct vision - Percutaneous arteriotomy closed with closure device Percutaneous arteriotomy closed using a plug-based arteriotomy closure device -
- Primary Outcome Measures
Name Time Method Major vascular groin-related complication according to the VARC-2 definition criteria During the first 8 weeks after surgery
- Secondary Outcome Measures
Name Time Method Access-site related groin seroma During the first 8 weeks after surgery Access-site related groin infection During the first 8 weeks after surgery Minor vascular groin-related complication according to the VARC-2 definition criteria During the first 8 weeks after surgery
Trial Locations
- Locations (1)
Karolinska University Hospital
🇸🇪Stockholm, Sweden